Liquidia (LQDA) Non Operating Income (2020 - 2026)
Liquidia (LQDA) recorded quarterly Non Operating Income of -$4.7 million in Q1 2026, up 9.75% quarter-over-quarter from -$5.2 million in Q4 2025, and down 60.5% on a YoY basis from -$12.0 million in Q1 2025.
Liquidia (LQDA) Non Operating Income (2020 - 2026) Analysis & Trends
Liquidia's Non Operating Income history runs 7 years deep, the most recent figure standing at -$4.7 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 60.5% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$19.3 million (down 123.26% YoY), while the FY2025 annual figure was -$17.5 million, down 150.79% from the prior year.
- Non Operating Income was -$4.7 million for Q1 2026 at Liquidia, up from -$5.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of -$36000.0 in Q4 2022 to a low of -$5.3 million in Q3 2025.
- Historically, Non Operating Income has averaged -$2.2 million across 5 years, with a median of -$1.5 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income soared 82.09% in 2022, then plunged 2716.67% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$36000.0 in 2022, then slumped by 2716.67% to -$1.0 million in 2023, then plunged by 136.98% to -$2.4 million in 2024, then tumbled by 117.73% to -$5.2 million in 2025, then increased by 9.75% to -$4.7 million in 2026.
- The last three Non Operating Income figures came in at -$4.7 million (Q1 2026), -$5.2 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.72 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Sep 30, 2025 | -5.30 Mn |
| Jun 30, 2025 | -4.07 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | -899,000.00 |
| Jun 30, 2023 | -692,000.00 |
| Mar 31, 2023 | -2.51 Mn |
| Dec 31, 2022 | -36,000.00 |
| Sep 30, 2022 | -261,000.00 |
| Jun 30, 2022 | -477,000.00 |
| Mar 31, 2022 | -1.47 Mn |
| Dec 31, 2021 | -201,000.00 |
| Sep 30, 2021 | -201,000.00 |
| Jun 30, 2021 | -198,000.00 |